Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms

NCT00403546 is registered in ClinicalTrials.gov with Donald C. Goff, MD as lead sponsor.

NCT NCT00403546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00403546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms
Lead sponsor
Donald C. Goff, MD
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2006
Completion date
May 31, 2011
Enrollment
131 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia